Antimicrobial-Drug Use and Changes in Resistance in Streptococcus pneumoniae

Resistance of Streptococcus pneumoniae to antimicrobial drugs is increasing. To investigate the relationship between antimicrobial use and susceptibility of S. pneumoniae isolates at 24 U.S. medical centers, we obtained data on outpatient antimicrobial-drug use for the regions surrounding 23 of thes...

Full description

Bibliographic Details
Main Authors:	Daniel J. Diekema, Angela B. Brueggemann, Gary V. Doern
Format:	Article
Language:	English
Published:	Centers for Disease Control and Prevention 2000-10-01
Series:	Emerging Infectious Diseases
Subjects:	Antimicrobial-Drug use beta-lactam antimicrobial drugs Streptococcus pneumoniae United States
Online Access:	https://wwwnc.cdc.gov/eid/article/6/5/00-0519_article

id	doaj-1cbd9c5a00fc4623aaa1723ed2481788
record_format	Article
spelling	doaj-1cbd9c5a00fc4623aaa1723ed24817882020-11-25T00:49:04ZengCenters for Disease Control and PreventionEmerging Infectious Diseases1080-60401080-60592000-10-016555255610.3201/eid0605.000519Antimicrobial-Drug Use and Changes in Resistance in Streptococcus pneumoniaeDaniel J. DiekemaAngela B. BrueggemannGary V. DoernResistance of Streptococcus pneumoniae to antimicrobial drugs is increasing. To investigate the relationship between antimicrobial use and susceptibility of S. pneumoniae isolates at 24 U.S. medical centers, we obtained data on outpatient antimicrobial-drug use for the regions surrounding 23 of these centers. We found an association between decreased penicillin susceptibility and use of beta-lactam antimicrobial drugs.https://wwwnc.cdc.gov/eid/article/6/5/00-0519_articleAntimicrobial-Drug usebeta-lactam antimicrobial drugsStreptococcus pneumoniaeUnited States
collection	DOAJ
language	English
format	Article
sources	DOAJ
author	Daniel J. Diekema Angela B. Brueggemann Gary V. Doern
spellingShingle	Daniel J. Diekema Angela B. Brueggemann Gary V. Doern Antimicrobial-Drug Use and Changes in Resistance in Streptococcus pneumoniae Emerging Infectious Diseases Antimicrobial-Drug use beta-lactam antimicrobial drugs Streptococcus pneumoniae United States
author_facet	Daniel J. Diekema Angela B. Brueggemann Gary V. Doern
author_sort	Daniel J. Diekema
title	Antimicrobial-Drug Use and Changes in Resistance in Streptococcus pneumoniae
title_short	Antimicrobial-Drug Use and Changes in Resistance in Streptococcus pneumoniae
title_full	Antimicrobial-Drug Use and Changes in Resistance in Streptococcus pneumoniae
title_fullStr	Antimicrobial-Drug Use and Changes in Resistance in Streptococcus pneumoniae
title_full_unstemmed	Antimicrobial-Drug Use and Changes in Resistance in Streptococcus pneumoniae
title_sort	antimicrobial-drug use and changes in resistance in streptococcus pneumoniae
publisher	Centers for Disease Control and Prevention
series	Emerging Infectious Diseases
issn	1080-6040 1080-6059
publishDate	2000-10-01
description	Resistance of Streptococcus pneumoniae to antimicrobial drugs is increasing. To investigate the relationship between antimicrobial use and susceptibility of S. pneumoniae isolates at 24 U.S. medical centers, we obtained data on outpatient antimicrobial-drug use for the regions surrounding 23 of these centers. We found an association between decreased penicillin susceptibility and use of beta-lactam antimicrobial drugs.
topic	Antimicrobial-Drug use beta-lactam antimicrobial drugs Streptococcus pneumoniae United States
url	https://wwwnc.cdc.gov/eid/article/6/5/00-0519_article
work_keys_str_mv	AT danieljdiekema antimicrobialdruguseandchangesinresistanceinstreptococcuspneumoniae AT angelabbrueggemann antimicrobialdruguseandchangesinresistanceinstreptococcuspneumoniae AT garyvdoern antimicrobialdruguseandchangesinresistanceinstreptococcuspneumoniae
_version_	1725253224897708032

Antimicrobial-Drug Use and Changes in Resistance in Streptococcus pneumoniae

Similar Items